The acquisition of Tissue Analytics expands Net Health’s leadership position within the wound care market, and it is intended to accelerate delivery of wound care technology solutions, including predictive analytics.
“This acquisition enhances our ability to support wound care providers and strengthen their impact on patient outcomes,” said Net Health CEO Josh Pickus. “By combining our solutions, we can now extend our product capabilities and expand the settings in which we can help customers — adding inpatient settings to the hospital outpatient market we presently serve and growing our presence in post- acute settings and wound care therapies product development.”
Tissue Analytics solutions are used by hospitals, individual clinicians and product manufacturers for delivery of wound care services as well as management of clinical trials. Capabilities include:
• Rich wound imaging and automated measurement technology enabling highly consistent 2D and 3D wound measurements
• A mobile application for patient use that allows providers to monitor chronic wounds remotely
• Deep integration with well-known hospital EHR systems, facilitating seamless delivery of wound care in both inpatient and outpatient settings
• Advanced machine learning algorithms and expertise critical to the expansion of predictive analytics in wound care and other clinical specialties
Tissue Analytics applications will be integrated with Net Health’s WoundExpert EHR solution to add key capabilities for use within hospital outpatient settings. Clinicians will be able to capture and seamlessly upload wound images and other documentation, including automated measurements, to the WoundExpert platform.
Net Health is a portfolio company of The Carlyle Group, Level Equity and Silversmith Capital Partners.